Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
Recruiting · NCT06104371 · Observational (researchers observe without assigning treatment) · Lead sponsor: Vastra Gotaland Region
View the official record on ClinicalTrials.gov →Interventions studied
Magtrace
What this trial is about
Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients 18 years of age or older.
- Patients with breast cancer planned to undergo NACT with
- planned sentinel lymph node dissection (SLND), or
- targeted axillary lymph node dissection (TAD), in conjunction with the
- breast surgery after NACT.
Exclusion criteria
- Intolerance / hypersensitivity to iron or dextran compounds or SPIO.
- Patients who are required to undergo MRI to evaluate tumour response.
- Pregnancy or breast feedin.g
- Patients with an iron overload disease.
- Patient deprived of liberty or under guardianship.
- Inability to understand given information and give informed consent or undergo study procedure
Where it is running
1 location listed.
- Sahlgrenska University Hospital - Gothenburg, Sweden